TWST: Please begin with a brief overview of PDL BioPharma?
Mr. McLaughlin: Sure. PDL is a biotech company. We're publicly traded, and we're a little different from most biotech companies in the sense that we don't do researc
Pharmaceuticals >> CEO Interview >> September 17, 2012
PDL BioPharma, Inc. (PDLI)
John P. McLaughlin was elected a Director of PDL BioPharma, Inc., in October 2008. He has been the company’s President and Chief Executive Officer since December 2008, after the company spun off Facet Biotech Corporation. From November 2008 until the spinoff, he served as a Senior Adviser to the company... More
